ReviewF1000prime reports2014
Management of pediatric uveitis.
Review in F1000prime reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 43 citations in OpenAlex.
- Association of uveitis with pediatric autoimmune diseases based on a TriNetX study.Scientific reports · 2024Article
- Bilateral anterior uveitis as a presenting feature of Juvenile Xanthogranuloma in a neonate.American journal of ophthalmology case reports · 2023Article
- Clinical and therapeutic characteristics of childhood uveitis in a tertiary center in Tunisia.La Tunisie medicale · 2023Article
- Paediatric anterior uveitis management in the USA: a single-centre, 10-year retrospective chart review exploring the efficacy and safety of systemic immunomodulatory therapy.Eye (London, England) · 2023Article
- Article
- Follow-up Findings of Non-infectious Pediatric Uveitis Patients.Turkish journal of ophthalmology · 2021Article
- JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis.Clinical rheumatology · 2020Article
- Genetic aspects of idiopathic paediatric uveitis and juvenile idiopathic arthritis associated uveitis in Chinese Han.The British journal of ophthalmology · 2020Article
- Update on the management of uveitis in children: an overview for the clinician.Expert review of ophthalmology · 2019Article
- Observational
- Use of Immunosuppressive Medications for Treatment of Pediatric Intermediate Uveitis.Ocular immunology and inflammation · 2018Article
- Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.Turkish journal of ophthalmology · 2016Review
- A 10-year review of pediatric uveitis at a Hispanic-dominated tertiary pediatric ophthalmic clinic.Clinical ophthalmology (Auckland, N.Z.) · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric uveitis is a topic of special interest not only because of the unique diagnostic and therapeutic challenges but also because of the lifetime burden of vision loss if the problem is not adequately treated, as well as the economic and psychological toll on the family. Often, uveitis in children is discovered as part of a routine eye exam; this silent, insidious inflammation can be difficult to treat and can lead to further complications if not handled skillfully. Corticosteroids have long been the mainstay of therapy; however, the significant associated side effects mandate a corticosteroid-sparing therapeutic regimen in pursuit of remission. In this review, we cover the therapeutic options for pediatric uveitis, specifically focusing on the most common non-infectious varieties, juvenile idiopathic arthritis-associated uveitis and pars planitis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.